Sens. Grassley and Hassan Introduce Stop Pills That Kill Act to Target Counterfeit Fentanyl
The Stop Pills That Kill Act is currently in the early stages of the legislative process. It was recently introduced in the Senate and sent to the Committee on the Judiciary for review. There are no upcoming votes scheduled at this time.
No action since October 2025
This bill has support from both parties and addresses a major public health crisis, which usually helps a bill move forward. However, many similar bills face delays in the busy legislative calendar.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 4105 (118th), which died when its Congress ended.
H.R. 4105 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
The bill expands federal criminal penalties to explicitly cover fentanyl, fentanyl analogues, and counterfeit substances under the Controlled Substances Act. People caught manufacturing, distributing, or possessing counterfeit pills containing these drugs would face enhanced federal charges, leading to more prosecutions and longer sentences for those convicted.
“Section 403(d)(2) of the Controlled Substances Act (21 U.S.C. 843(d)(2)) is amended, in the matter preceding subparagraph (A), by inserting ``, fentanyl, an analogue of fentanyl, or a counterfeit substance'' after ``methamphetamine''”
Read twice and referred to the Committee on the Judiciary.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Stop Pills That Kill Act
Analysis generated by AI. Always verify with official sources.